Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-051551

Chief Executive Officer acquired 40,624 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Anzalone Christopher Richard · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-09-27 Exercise or conversion : show line 1 in the form −39,082 $30.77 $1,202,553 3,469,856 D
2022-09-27 Exercise or conversion : show line 2 in the form −1,542 $31.21 $48,126 3,468,314 D
Loading xslF345X03/doc4.xml…